A detailed history of Aqr Capital Management LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 329,794 shares of CDNA stock, worth $7.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
329,794
Previous 180,059 83.16%
Holding current value
$7.37 Million
Previous $2.8 Million 268.24%
% of portfolio
0.01%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$14.41 - $33.99 $2.16 Million - $5.09 Million
149,735 Added 83.16%
329,794 $10.3 Million
Q2 2024

Aug 14, 2024

SELL
$7.56 - $16.15 $2.03 Million - $4.35 Million
-269,082 Reduced 59.91%
180,059 $2.8 Million
Q1 2024

May 15, 2024

BUY
$7.96 - $12.37 $1.98 Million - $3.07 Million
248,519 Added 123.87%
449,141 $4.76 Million
Q4 2023

Feb 14, 2024

SELL
$4.9 - $12.86 $567,518 - $1.49 Million
-115,820 Reduced 36.6%
200,622 $2.41 Million
Q3 2023

Nov 14, 2023

SELL
$7.0 - $11.26 $146,258 - $235,266
-20,894 Reduced 6.19%
316,442 $2.22 Million
Q2 2023

Aug 14, 2023

BUY
$7.61 - $9.46 $1.73 Million - $2.15 Million
227,709 Added 207.71%
337,336 $2.87 Million
Q1 2023

May 15, 2023

BUY
$8.83 - $17.61 $502,947 - $1 Million
56,959 Added 108.15%
109,627 $1 Million
Q4 2022

Feb 14, 2023

BUY
$10.88 - $20.05 $235,671 - $434,303
21,661 Added 69.86%
52,668 $600,000
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $497,972 - $818,274
31,007 New
31,007 $528,000
Q2 2022

Aug 15, 2022

SELL
$20.49 - $39.72 $466,577 - $904,464
-22,771 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$28.19 - $46.6 $108,305 - $179,037
-3,842 Reduced 14.44%
22,771 $842,000
Q4 2021

Feb 14, 2022

SELL
$41.2 - $73.6 $39,593 - $70,729
-961 Reduced 3.49%
26,613 $1.21 Million
Q3 2021

Nov 15, 2021

SELL
$59.15 - $91.99 $33,478 - $52,066
-566 Reduced 2.01%
27,574 $1.75 Million
Q2 2021

Aug 16, 2021

SELL
$63.02 - $95.11 $177,653 - $268,115
-2,819 Reduced 9.11%
28,140 $2.58 Million
Q1 2021

May 17, 2021

BUY
$57.62 - $95.6 $438,776 - $727,994
7,615 Added 32.62%
30,959 $2.11 Million
Q4 2020

Feb 16, 2021

BUY
$41.43 - $77.09 $351,699 - $654,417
8,489 Added 57.15%
23,344 $1.69 Million
Q3 2020

Nov 16, 2020

BUY
$30.88 - $37.94 $37,673 - $46,286
1,220 Added 8.95%
14,855 $564,000
Q2 2020

Aug 17, 2020

BUY
$18.95 - $35.43 $17,604 - $32,914
929 Added 7.31%
13,635 $483,000
Q1 2020

May 15, 2020

SELL
$13.94 - $28.25 $537,136 - $1.09 Million
-38,532 Reduced 75.2%
12,706 $277,000
Q4 2019

Feb 14, 2020

SELL
$19.24 - $28.41 $1.81 Million - $2.67 Million
-94,048 Reduced 64.73%
51,238 $1.11 Million
Q3 2019

Nov 14, 2019

SELL
$20.03 - $40.08 $4.01 Million - $8.02 Million
-200,187 Reduced 57.95%
145,286 $3.29 Million
Q2 2019

Aug 14, 2019

SELL
$25.78 - $39.77 $809,775 - $1.25 Million
-31,411 Reduced 8.33%
345,473 $12.4 Million
Q1 2019

May 14, 2019

BUY
$22.09 - $39.21 $1.55 Million - $2.76 Million
70,269 Added 22.92%
376,884 $11.9 Million
Q4 2018

Feb 14, 2019

BUY
$19.89 - $30.02 $2.19 Million - $3.31 Million
110,316 Added 56.2%
306,615 $7.71 Million
Q3 2018

Nov 15, 2018

BUY
$12.1 - $28.85 $315,822 - $753,013
26,101 Added 15.34%
196,299 $5.66 Million
Q2 2018

Aug 14, 2018

BUY
$7.93 - $15.79 $1.35 Million - $2.69 Million
170,198 New
170,198 $2.08 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.19B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.